American Joint Committee on Cancer. (2002). Cancer staging manual (6th ed.). New York: Springer-Verlag.
Balduzzi, A., Leonardi, M. C., Cardillo, A., Orecchia, R., Dellapasqua, S., Iorfida, M., et al. (2010). Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treatment Reviews, 36(6), 443–450 Epub 2010 Mar 20.
Benk, V., Przybysz, R., McGowan, T., & Paszat, L. (2006). Waiting times for radiation therapy in Ontario. Canadian Journal of Surgery, 49(1), 16–21.
Canadian Cancer Society’s Steering Committee. Canadian Cancer Statistics. (2011). Toronto (p. 2011). ON: Canadian Cancer Society.
Cancer Care Ontario. (2010).Wait Times. from: http://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=8836. Accessed 04/29/2013, 2013.
Cancer Care Ontario. (2016). Ontario Cancer Screening Performance Report 2016. Toronto.
Caplan, L. S., May, D. S., & Richardson, L. C. (2000). Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. American Journal of Public Health, 90(1), 130–134.
Chen, Z., King, W., Pearcey, R., Kerba, M., & Mackillop, W. J. (2008). The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiotherapy and Oncology, 87(1), 3–16 Epub 2007 Dec 21.
Chiarelli, A. M., Edwards, S. A., Prummel, M. V., Muradali, D., Majpruz, V., Done, S. J., et al. (2013). Digital compared with screen-film mammography: performance measures in concurrent cohorts within an organized breast screening program. Radiology., 268(3), 684–693.
Chiarelli, A. M., Muradali, D., Blackmore, K. M., Smith, C. R., Mirea, L., Majpruz, V., et al. (2017). Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care. British Journal of Cancer, 116(10), 1254.
Hammond, M. E., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., et al. (2010). American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Archives of Pathology & Laboratory Medicine, 134(7), e48–e72.
Haynes, W. (2013). Wilcoxon rank sum test. In Encyclopedia of Systems Biology (pp. 2354–2355). Berlin: Springer.
Huang, J., Barbera, L., Brouwers, M., Browman, G., & Mackillop, W. J. (2003). Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. Journal of Clinical Oncology, 21(3), 555–563.
Jaro, M. A. (1995). Probabilistic linkage of large public health data files. Statistics in Medicine, 14(5–7), 491–498.
Lohrisch, C., Paltiel, C., Gelmon, K., Speers, C., Taylor, S., Barnett, J., et al. (2006). Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. Journal of Clinical Oncology, 24(30), 4888–4894 Epub 2006 Oct 2.
Olivotto, I. A., Lesperance, M. L., Truong, P. T., Nichol, A., Berrang, T., Tyldesley, S., et al. (2009). Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. Journal of Clinical Oncology, 27(1), 16–23 Epub 2008 Nov 17.
Ontario Breast Screening Program. (2001). Multidisciplinary Roles and Expectations for Breast Assessment in Ontario. Toronto: The Breast Assessment Collaborative Group.
Plotogea, A., Chiarelli, A. M., Mirea, L., Prummel, M. V., Chong, N., Shumak, R. S., et al. (2013). Factors associated with wait times across the breast cancer treatment pathway in Ontario. SpringerPlus, 2(1), 388. https://doi.org/10.1186/2193-1801-2-388.
Punglia, R. S., Saito, A. M., Neville, B. A., Earle, C. C., & Weeks, J. C. (2010). Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. Bmj., 340, c845.
Quan, M. L., Shumak, R. S., Majpruz, V., Holloway, C. M., O’Malley, F. P., & Chiarelli, A. M. (2012). Improving work-up of the abnormal mammogram through organized assessment: results from the ontario breast screening program. Journal of Oncology Practice/ American Society of Clinical Oncology, 8(2), 107–112.
Rayson, D., Chiasson, D., & Dewar, R. (2004). Elapsed time from breast cancer detection to first adjuvant therapy in a Canadian province, 1999-2000. CMAJ., 170(6), 957–961.
Rayson, D., Saint-Jacques, N., Younis, T., Meadows, J., & Dewar, R. (2007). Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04. CMAJ., 176(3), 327–332.
Saint-Jacques, N., Younis, T., Dewar, R., & Rayson, D. (2007 12/1906/30/received11/10/revised11/13/accepted). Wait times for breast cancer care. British Journal of Cancer, 96(1), 162–168.
SAS Institute Inc. (2013). Statistical Analysis Software, 9.4 ed. Cary: SAS Institute.
Smith, C. R., Chiarelli, A. M., Holloway, C. M., Mirea, L., O'Malley, F. P., Blackmore, K. M., et al. (2018). The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer. The Breast, 41, 25–33.
Statistics Canada. Postal code conversion file plus (PCCF+), reference guide, 2014.
Vujovic, O., Yu, E., Cherian, A., Perera, F., Dar, A. R., Stitt, L., et al. (2009). Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. International Journal of Radiation Oncology, Biology, Physics, 75(3), 771–774.
Whelan, T. J., Julian, J., Wright, J., Jadad, A. R., & Levine, M. L. (2000). Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. Journal of Clinical Oncology, 18(6), 1220–1229 e-pub ahead of print 2000/03/15.
Whelan, T., Olivotto, I., & Levine, M. (2003). Health Canada’s Steering Committee on Clinical Practice Guidelines for the C, Treatment of Breast C. Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update). CMAJ., 168(4), 437–439.
Wolff, A. C., Hammond, M. E., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., et al. (2007). American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Archives of Pathology & Laboratory Medicine, 131(1), 18–43.